SCHEMBL6937592

SCHEMBL6937592

Cn1cc(CC[C@H](O)CO)c2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.58
GPR84 Q9NQS5 1/20 0.56
KDM4E B2RXH2 2/20 0.50
KEAP1 Q14145 1/20 0.50
NFE2L2 Q16236 1/20 0.50
HPGD P15428 1/20 0.50
HSD17B10 Q99714 1/20 0.50
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
IDO1 P14902 1/20 0.48
SLC6A4 P31645 1/20 0.46
TP53 P04637 2/20 0.45
CCNE2 O96020 1/20 0.45
CDK4 P11802 1/20 0.45
CCND1 P24385 1/20 0.45
CCNE1 P24864 1/20 0.45
CDK2 P24941 1/20 0.45
LMNA P02545 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
GRM2 Q14416 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6937603 1.00 HTR2A (0.58) HTR2AGPR84KDM4EKEAP1NFE2L2
SCHEMBL14021899 0.81 HTR2A (0.65) HTR2AGPR84KDM4EKEAP1NFE2L2
SCHEMBL5402680 0.80 HTR2A (0.69) HTR2AGPR84KDM4EKEAP1NFE2L2
SCHEMBL1094688 0.78 GPR84 (0.74) HTR2AGPR84KDM4EKEAP1NFE2L2
SCHEMBL14610760 0.78 GPR84 (0.59) HTR2AGPR84KDM4EKEAP1NFE2L2
SCHEMBL23677880 0.78 KDM4E (0.50) HTR2AGPR84KDM4EHPGDHSD17B10
SCHEMBL5635157 0.78 HTR2A (0.65) HTR2AGPR84KDM4EKEAP1NFE2L2
SCHEMBL29834888 0.78 HTR2A (0.65) HTR2AGPR84KDM4EKEAP1NFE2L2
SCHEMBL6941459 0.77 ADA (0.52) MEN1KMT2A
SCHEMBL6941454 0.77 ADA (0.52) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596738-B1 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-22 US disclosed
EP-1161429-A2 HETEROCYCLIC COMPOUNDS AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-12-12 EP disclosed
WO-2000055155-A2 HETEROCYCLIC COMPOUNDS AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-09-21 WO disclosed